News
New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...
Daniel Drucker, Ozempic’s father: ‘I’m very conservative. I don’t sell the drugs. I study the drugs’
The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...
Metformin is a safe, effective and cheap, and is showing it has promise for longevity, long Covid, weight control and other ...
Obesity is not a personal moral failing. It is a complex, multi-factorial condition driven by genetics, environment, and a ...
2d
Best Life on MSNDoctors Sound Alarm on Weight-Loss Drugs and Death RiskRELATED: Doctors Warn That Drugs Like Ozempic Are Making You “Skinny Fat.” Any time a person suddenly loses weight, they are ...
The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...
Dear J.H.: Metformin, a treatment for diabetes that works mostly by preventing the liver from making sugar, isn't new and has ...
5d
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results